Blockchain Registration Transaction Record
Tonix Pharmaceuticals to Present Real-World Fibromyalgia Data at ISPOR 2026
Tonix Pharmaceuticals presents real-world fibromyalgia data at ISPOR 2026 following TONMYA approval. Learn about TNXP's CNS and immunology pipeline.
This news matters because Tonix's TONMYA is the first new fibromyalgia treatment in over 15 years, offering hope to millions of patients who have had limited therapeutic options. Real-world data from this study could validate TONMYA's effectiveness in everyday clinical settings, potentially influencing prescribing practices and insurance coverage. For investors, positive data may boost confidence in Tonix's commercial strategy and pipeline, including its broader CNS and immunology programs.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x097089c8f34dd19cf98fbbaa5a87dd07f93c33a071b27f2cc1c9894b0dd6e169 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | fernNajs-27217f540828dd5f71f870df06472664 |